A year and a half af­ter Cel­lar­i­ty raised $123M, the Flag­ship biotech is back — and it's ready to pick out can­di­dates

Cel­lar­i­ty doesn’t have any lead can­di­dates yet. It doesn’t even have a pub­lic pipeline.

But it’s still at­tract­ing new in­vestors. In a third round of fi­nanc­ing an­nounced this morn­ing, Cel­lar­i­ty raised $121 mil­lion — just $2 mil­lion short of its last round — and brought on four new in­vestors, in­clud­ing Ky­owa Kirin and Han­wha Im­pact Part­ners.

Flag­ship, where the start­up was first con­ceived, al­so par­tic­i­pat­ed in the lat­est round. Most of its oth­er for­mer in­vestors re­turned as well, Cel­lar­i­ty CEO Fab­rice Chouraqui told End­points News, though he would not dis­close which ones.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER